As atopic dermatitis (AD) prevalence has increased in children over several decades, it's critical for physicians to recognize the environmental and demographic factors contributing to the change, said Jonathan Silverberg, MD, PhD, MPH.
Jonathan Silverberg, MD, PhD, MPH, is an associate professor of dermatology at George Washington University School of Medicine and Health Sciences.
Transcript:
Why is it important to quantify the prevalence of atopic dermatitis in children?
Silverberg: Prevalence is a little bit of a complicated statistic to interpret in general because it reflects not only more incident cases but it also reflects more persistent cases over time and a composite overall assessment of the state of how common a disease can be. What we've seen is that over the past 40 to 50 years, there's been this steady increase in the prevalence of atopic dermatitis and there has been some real questions about whether or not it's continuing to increase. Why that matters is severalfold: one, because this is a disease that is highly related to environmental factors so with changing environmental factors, there may be an increase in prevalence and [two] there are fascinating differences by demographic factors as well and with a growing diversification of the population, we might expect to see changes in the prevalence.
So, that's some of the background. Overall, the importance is atopic dermatitis is arguably one of, if not the most, common chronic disease of childhood. It's even more common than asthma in children. For many children it's a mild disease, but for a large subset, it's very debilitating and chronic. These are patients that are really suffering. So, from a resource allocation standpoint and from an understanding of how commonly different medications may be used in a therapeutic landscape, these are all very important applications of where prevalence comes into play.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More